71/100 B+ · Elevated risk
No major risk flags in public sources TraceComp due-diligence verdict — sanctions, screening, insolvency, control & financial signals combined.

✅ No sanctions, screening, insolvency or control red flags found in the public sources we cover. (Absence of a flag is not a guarantee — see methodology.)

Avinger Inc

Active operating 📍 redwood city, ca 3841

operating · RC 0001506928

B+

Overview

Avinger Inc is a operating registered in REDWOOD CITY, CA, United States. The company operates in the 3841 sector. With reported revenue of 9.9M USD in 2023. Its TraceComp score of 71 (B+) indicates moderate risk with some areas to watch.

Company Information

Registration Number
0001506928
Legal Form
operating
Address
redwood city, ca

Financial Profile

Latest filed accounts: FY 2023 · most recent available in public filings

Revenue (2023) 9,934,000 USD
Net Income -18,320,000 USD
Total Assets 13,770,000 USD
Altman Z -3.93 distress

Multi-year financials & ratios

1 year of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Officers & Management

No officers on record.

Research Output

Active research organization. 6 publications · 236 citations · h-index 6 in the global scholarly record (OpenAlex — 82.9M papers). Top fields by publication volume: Medicine (63%) · Neuroscience (13%) · Biochemistry, Genetics and Molecular Biology (13%).

See full research profile — top researchers & publications →

Source: OpenAlex (CC0). Objective publication & citation counts.

Patent Portfolio

Active patent holder. 76 patents · 76 active · 76 granted in the USPTO/EPO record.

See full patent portfolio — most-cited inventions & inventors →

Source: USPTO / EPO open patent data. Objective bibliographic counts.

Risk Signals

No adverse legal events have been recorded for this company.

  • Net loss reported in FY 2023
  • Altman Z-Score in the distress zone — elevated insolvency risk on the model

Data Sources & Freshness

Data sourced from: bulk register.